These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 18814025)
21. Inadequate iron availability as a possible cause of low serum carnitine concentrations in patients with phenylketonuria. Böhles H; Ullrich K; Endres W; Behbehani AW; Wendel U Eur J Pediatr; 1991 Apr; 150(6):425-8. PubMed ID: 2040352 [TBL] [Abstract][Full Text] [Related]
22. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies. Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347 [TBL] [Abstract][Full Text] [Related]
23. The relationship between dietary intake, growth and body composition in Phenylketonuria. Evans M; Truby H; Boneh A Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202 [TBL] [Abstract][Full Text] [Related]
24. Optimal serum phenylalanine for adult patients with phenylketonuria. Okano Y; Nagasaka H Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552 [TBL] [Abstract][Full Text] [Related]
25. Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation. Ribas GS; Biancini GB; Mescka C; Wayhs CY; Sitta A; Wajner M; Vargas CR Cell Mol Neurobiol; 2012 Jan; 32(1):77-82. PubMed ID: 21833551 [TBL] [Abstract][Full Text] [Related]
26. Haemostatic variables in phenylketonuric children under dietary treatment. Schulpis KH; Platokouki H; Papakonstantinou ED; Adamtziki E; Bargeliotis A; Aronis S J Inherit Metab Dis; 1996; 19(5):603-9. PubMed ID: 8892015 [TBL] [Abstract][Full Text] [Related]
27. Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria. Vernon HJ; Koerner CB; Johnson MR; Bergner A; Hamosh A Mol Genet Metab; 2010 Jul; 100(3):229-33. PubMed ID: 20418136 [TBL] [Abstract][Full Text] [Related]
28. Metabolomics of dietary fatty acid restriction in patients with phenylketonuria. Mütze U; Beblo S; Kortz L; Matthies C; Koletzko B; Bruegel M; Rohde C; Thiery J; Kiess W; Ceglarek U PLoS One; 2012; 7(8):e43021. PubMed ID: 22912778 [TBL] [Abstract][Full Text] [Related]
29. Decreasing oxidative stress with choline and carnitine in women. Sachan DS; Hongu N; Johnsen M J Am Coll Nutr; 2005 Jun; 24(3):172-6. PubMed ID: 15930482 [TBL] [Abstract][Full Text] [Related]
30. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065 [TBL] [Abstract][Full Text] [Related]
31. Lipid profile status and other related factors in patients with Hyperphenylalaninaemia. Couce ML; Vitoria I; Aldámiz-Echevarría L; Fernández-Marmiesse A; Roca I; Llarena M; Sánchez-Pintos P; Leis R; Hermida A Orphanet J Rare Dis; 2016 Sep; 11(1):123. PubMed ID: 27612877 [TBL] [Abstract][Full Text] [Related]
33. Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria. Ney DM; Hull AK; van Calcar SC; Liu X; Etzel MR J Nutr; 2008 Feb; 138(2):316-22. PubMed ID: 18203898 [TBL] [Abstract][Full Text] [Related]
34. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density. Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525 [TBL] [Abstract][Full Text] [Related]
35. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Schulpis KH; Tsakiris S; Traeger-Synodinos J; Papassotiriou I Clin Biochem; 2005 Mar; 38(3):239-42. PubMed ID: 15708545 [TBL] [Abstract][Full Text] [Related]
36. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria. Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331 [TBL] [Abstract][Full Text] [Related]
37. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model. Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767 [TBL] [Abstract][Full Text] [Related]
38. Dietary glycemic index, glycemic load and metabolic profile in children with phenylketonuria. Moretti F; Pellegrini N; Salvatici E; Rovelli V; Banderali G; Radaelli G; Scazzina F; Giovannini M; Verduci E Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):176-182. PubMed ID: 28081989 [TBL] [Abstract][Full Text] [Related]
39. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU). Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376 [TBL] [Abstract][Full Text] [Related]
40. Serum selenium levels in individuals on PKU diets. Darling G; Mathias P; O'Regan M; Naughten E J Inherit Metab Dis; 1992; 15(5):769-73. PubMed ID: 1434516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]